Rapid diagnostics
Three core pillars enabling high-volume, privacy-conscious, and economically scalable diagnostics.
CENTiV™ is designed to eliminate cold-chain dependence and dramatically increase diagnostic density.
The roll-based format reduces freight intensity and storage footprint, positioning the platform for scalable deployment once industrialized.
Industrial-scale output without industrial-scale logistics.
CENTiV™ dispenses 100 tests from a single handheld unit, reducing repetitive pouch handling and material waste. Mechanical safeguards are integrated directly into the test format to reduce variability in sampling and timing.
High-volume testing with engineered control.
Bridging the Physical and Digital
CENTiV™ extends rapid testing beyond visual interpretation through optical verification and offline-first data design. The platform supports scalable digital deployment while protecting patient privacy.
From individual tests to secure digital intelligence.
About Dianovo
Vision
Want to learn more?
Contact us!
Conventional lateral flow tests rely on cold-chain logistics, low-density packaging, and plastic-heavy housings. These constraints increase freight exposure, storage burden, and distribution complexity. CENTiV™ addresses these limitations at the system level.
Condenses one million tests from approximately 80–120 m³ to around 5 m³, depending on comparator format and packaging baseline.
Higher shipment density reduces freight burden, storage footprint, and handling complexity. In global procurement, logistics and packaging can represent a significant share of total landed diagnostic cost.
Independence from the Cold Chain
Reagents are stabilized in a glass-like solid state designed to remain active in elevated temperatures. The platform operates without refrigeration, supporting deployment in infrastructure-limited and tropical environments.
Roll-to-Roll Manufacturing Compatibility
The roll-based format is compatible with high-speed reel-to-reel production and eliminates manual cassette assembly steps inherent to conventional formats. This design positions the platform for substantially higher throughput once industrialized.
Rigid plastic housings are replaced with predominantly wood-based materials, significantly reducing plastic mass and downstream disposal burden.
Mechanical safeguards integrated directly into the test format.
High-volume screening environments introduce variability in sampling, timing, and handling. CENTiV™ integrates physical sequencing controls to reduce common sources of user error and support consistent execution.
The Smart Start Guard
A mechanical sequencing mechanism prevents assay initiation until the required sample threshold is met. Buffer release and timing are governed mechanically to reduce run variability.
Designed for Signal Clarity
The format accommodates a larger effective sample volume than conventional lateral flow designs. This choice strengthens biological signal intensity and supports clearer visual and digital interpretation.
Structural Stability Without Plastic
As the strip exits the unit, its engineered geometry forms a rigid beam structure. This removes the need for a bulky plastic cassette while preserving handling stability.
Bio-Safety Separation
The biological sample remains on the dispensed strip and does not re-enter the device housing. Unlike rewind-based continuous systems, used strips do not return into the enclosure. This separation reduces cross-contamination pathways and maintains device integrity.
Sustainable Material Format
Predominantly wood-based materials replace rigid plastic housings, lowering hazardous waste volume while maintaining durability during use.
Extending rapid diagnostics into secure digital intelligence.
Traditional rapid tests conclude with visual interpretation. CENTiV™ integrates optical verification and secure data design to extend testing into structured, privacy-conscious digital workflows.
Accessible Digital Platform
Structural identifiers are embedded into the test substrate, enabling simplified reader design without embedded electronic chips. This reduces system complexity and supports scalable digital deployment.
Optical Signal Verification
Near-infrared interrogation reduces visual interference and supports consistent interpretation across varied sample conditions.
Workflow Privacy
A timed visual obscuring mechanism darkens the result window after an initial interpretation period. Subsequent reading requires digital verification, supporting patient dignity in sensitive testing contexts and controlled visibility.
Secure Data Handling
The platform follows an offline-first data model. Results are stored locally and synchronized when connectivity becomes available, enabling deployment in low-infrastructure regions while supporting anonymized, population-level health insights when integrated into health systems.
Together, these elements position CENTiV™ as infrastructure for scalable, privacy-conscious diagnostic deployment.
Dianovo AB
Lund, Sweden
© 2026 Dianovo AB. All rights reserved.
Patent pending
P202250001
P202250002
Contact
Martin Lundberg
CEO and System Architect
martin@dianovohealth.com
Disclaimer: CENTiV™ is currently in development. Specifications, performance targets, and system features described on this website reflect design objectives and are subject to ongoing validation and regulatory review.